Biopharma Daily Stock Updates - 08/31/21

$XBI $132.84 +0.92%

---

Pipeline Updates

$EGRX +10.2% Eagle Pharmaceuticals Wins Vasopressin Patent Trial. source

$PSTX -19.3% Poseida Therapeutics Presents Preliminary Results from Phase 1 Trial of P-PSMA-101 at the 6th Annual CAR-TCR Summit. source

$JAZZ +0.1% Jazz Pharmaceuticals Announces Health Canada Approval of Sunosi® (solriamfetol) for Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea. source

$ACIU +16.3% AC Immune Announces First Positive Cognitive Results for a Tau-Targeting Monoclonal Antibody in Alzheimer’s Disease. source

$CYTK +1.0% Cytokinetics Announces Results From REDWOOD-HCM and GALACTIC-HF to Be Presented in Late Breaking Clinical Trials Session at the HFSA Annual Scientific Meeting. source

$AMRN -1.8% Amarin Reports Overview of Latest Clinical Research Evaluating VASCEPA®/VAZKEPA (Icosapent Ethyl) and Eicosapentaenoic Acid (EPA) Presented at ESC Congress 2021, Organized by the European Society of Cardiology. source

$EGRX +10.2% Eagle Pharmaceuticals Granted Additional Patent for Bendamustine Franchise. source

$GMTX 20.9% Gemini Therapeutics Announces Presentation of Previously Released Data from Its Ongoing Phase 2a Study of GEM103 at Clinical Trials at the Summit. source

$VLON +24.0%

Market Updates

$ASND +1.6% Ascendis Pharma A/S Announces Proposed Public Offering of ADSs. source

$VECT +18.3% VectivBio to Acquire Comet Therapeutics and Host R&D Day. source

---

Posted by FS